- Home
- ZD vs RXRX Comparison
ZD vs RXRX Comparison
Compare ZD & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZD
- RXRX
- Stock Information
- Founded
- ZD 1995
- RXRX 2013
- Country
- ZD United States
- RXRX United States
- Employees
- ZD N/A
- RXRX N/A
- Industry
- ZD Advertising
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- ZD Consumer Discretionary
- RXRX Health Care
- Exchange
- ZD Nasdaq
- RXRX Nasdaq
- Market Cap
- ZD 1.3B
- RXRX 2.0B
- IPO Year
- ZD 1999
- RXRX 2021
- Fundamental
- Price
- ZD $32.68
- RXRX $5.28
- Analyst Decision
- ZD Hold
- RXRX Buy
- Analyst Count
- ZD 6
- RXRX 5
- Target Price
- ZD $49.67
- RXRX $7.00
- AVG Volume (30 Days)
- ZD 603.4K
- RXRX 29.8M
- Earning Date
- ZD 08-06-2025
- RXRX 08-07-2025
- Dividend Yield
- ZD N/A
- RXRX N/A
- EPS Growth
- ZD 36.58
- RXRX N/A
- EPS
- ZD 1.76
- RXRX N/A
- Revenue
- ZD $1,415,839,000.00
- RXRX $59,790,000.00
- Revenue This Year
- ZD $7.37
- RXRX $23.51
- Revenue Next Year
- ZD $3.65
- RXRX $53.87
- P/E Ratio
- ZD $19.20
- RXRX N/A
- Revenue Growth
- ZD 3.24
- RXRX 29.32
- 52 Week Low
- ZD $29.15
- RXRX $3.79
- 52 Week High
- ZD $60.62
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- ZD 52.60
- RXRX 52.46
- Support Level
- ZD $32.13
- RXRX $4.80
- Resistance Level
- ZD $34.14
- RXRX $5.88
- Average True Range (ATR)
- ZD 1.40
- RXRX 0.38
- MACD
- ZD 0.23
- RXRX 0.03
- Stochastic Oscillator
- ZD 65.57
- RXRX 48.32
About ZD Ziff Davis Inc.
Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.